Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7354)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Karageorgopoulos DE, Allen J, Bhagani S. Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a “special population”? World J Hepatol 2015; 7(15): 1936-1952 [PMID: 26244068 DOI: 10.4254/wjh.v7.i15.1936] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i15/1936.htm |
| Number | Citing Articles |
| 1 |
María-Carlota Londoño, Mar Riveiro-Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget, María J. Devesa-Medina, Miguel Ángel Serra, Carmen A. Navascués, Carme Baliellas, Teresa Aldamiz-Echevarría, María L. Gutiérrez, Benjamín Polo-Lorduy, Isabel Carmona, Salvador Benlloch, Lucía Bonet, Javier García-Samaniego, Miguel Jiménez-Pérez, Senador Morán-Sánchez, Ángeles Castro, Manuel Delgado, Francisco Gea-Rodríguez, Ignacio Martín-Granizo, María Luisa Montes, Luís Morano, Manuel A. Castaño, Ignacio de los Santos, Montserrat Laguno, Juan Emilio Losa, Marta Montero-Alonso, Antonio Rivero, Cristina de Álvaro, Amanda Manzanares, Josep Mallolas, Guillermina Barril, Emilio González-Parra, Luisa García-Buey, Yury E. Khudyakov. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study. PLOS ONE 2019; 14(9): e0221567 doi: 10.1371/journal.pone.0221567
|
| 2 |
Cristina Stasi, Caterina Silvestri, Roberto Berni, Maurizia Rossana Brunetto, Anna Linda Zignego, Cristina Orsini, Stefano Milani, Liana Ricciardi, Andrea De Luca, Pierluigi Blanc, Cesira Nencioni, Donatella Aquilini, Alessandro Bartoloni, Giampaolo Bresci, Santino Marchi, Franco Filipponi, Piero Colombatto, Paolo Forte, Andrea Galli, Sauro Luchi, Silvia Chigiotti, Alessandro Nerli, Giampaolo Corti, Rodolfo Sacco, Paola Carrai, Angelo Ricchiuti, Massimo Giusti, Paolo Almi, Andrea Cozzi, Silvia Carloppi, Giacomo Laffi, Fabio Voller, Francesco Cipriani. Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany. Current Medical Research and Opinion 2019; 35(4): 661 doi: 10.1080/03007995.2018.1482264
|
| 3 |
Saman Mohazzab-Torabi, Fardin Dolatimehr, Heidar Sharafi, Mahdi Safi-Abadi , Mohammad Saeid Rezaee-Zavareh, Ehsan Bayatpour, Hamidreza Karimi-Sari, Seyed Moayed Alavian. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review. Hepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.82971
|
| 4 |
Hossam Abdelaziz, Heba Omar, Mahmoud Khalil, Ahmed Cordie, Rahma Mohamed, Mohamed AbdAllah, Mohammed Hamdy Abdel Maksoud, Naeema El Garhy, Lamiaa Ali, Magdy El Serafy, Gamal Esmat, Wahid Doss. Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience. Expert Review of Anti-infective Therapy 2022; 20(5): 789 doi: 10.1080/14787210.2022.2004117
|
| 5 |
Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito, Maria Cássia Mendes-Corrêa. Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus. Revista do Instituto de Medicina Tropical de São Paulo 2017; 59(0) doi: 10.1590/s1678-9946201759067
|
| 6 |
Fernanda Malta, Karine Vieira Gaspareto, Gaspar Lisboa-Neto, Flair José Carrilho, Maria Cássia Mendes-Correa, João Renato Rebello Pinho. Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2817-7
|
| 7 |
Mark Nelson, Rafael Rubio, Adriano Lazzarin, Svetlana Romanova, Annie Luetkemeyer, Brian Conway, Jean-Michel Molina, Dong Xu, Subasree Srinivasan, Simon Portsmouth. Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients. Journal of Interferon & Cytokine Research 2017; 37(3): 103 doi: 10.1089/jir.2016.0082
|
| 8 |
Cristina Stasi, Caterina Silvestri, Fabio Voller. Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination. SN Comprehensive Clinical Medicine 2020; 2(12): 2808 doi: 10.1007/s42399-020-00588-3
|
| 9 |
Kentaro Matsuura, Yasuhito Tanaka. Host genetic variations associated with disease progression in chronic hepatitis C virus infection. Hepatology Research 2018; 48(2): 127 doi: 10.1111/hepr.13042
|
| 10 |
I. P. Balmasova, M. S. Aristanbekova, E. S. Malova, R. I. Sepiashvili. MECHANISMS OF INTERACTION OF VIRAL CAUSATIVE AGENTS IN PATIENTS CO-INFECTED WITH HUMAN IMMUNODEFICIENCY AND HEPATITIS C VIRUSES. Journal of microbiology, epidemiology and immunobiology 2016; 93(5): 101 doi: 10.36233/0372-9311-2016-5-101-109
|
| 11 |
James Daniel Millard, Jaimie Henry, Syed Shoaib Rizvi, Mark Nelson. Direct-acting antivirals for acute hepatitis C in HIV-infected MSM. AIDS 2016; 30(13): 2137 doi: 10.1097/QAD.0000000000001157
|
| 12 |
Edison Mayanja, Livingstone S. Luboobi, Juma Kasozi, Rebecca N. Nsubuga, Raul Alcaraz. Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy. Computational and Mathematical Methods in Medicine 2020; 2020: 1 doi: 10.1155/2020/2106570
|
| 13 |
Khashayar Hesamizadeh, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, Bita Behnava, Seyed Moayed Alavian. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.37089
|
| 14 |
Damien Ulveling, Sigrid Le Clerc, Aurélie Cobat, Taoufik Labib, Josselin Noirel, Vincent Laville, Cédric Coulonges, Wassila Carpentier, Bertrand Nalpas, Markus H. Heim, Thierry Poynard, Andreas Cerny, Stanislas Pol, Pierre‐Yves Bochud, François Dabis, Ioannis Theodorou, Yves Lévy, Dominique Salmon, Laurent Abel, Stéphanie Dominguez, Jean‐François Zagury. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus‐coinfected patients. Hepatology 2016; 64(5): 1462 doi: 10.1002/hep.28695
|
| 15 |
David Rey, Patrice Muret, Lionel Piroth. Optimum combination therapy regimens for HIV/HCV infection. Expert Review of Anti-infective Therapy 2016; 14(3): 299 doi: 10.1586/14787210.2016.1147952
|